SCHEMBL5528149

SCHEMBL5528149

COC(=O)Cc1ccc(CO)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.51
CYP4A11 Q02928 1/20 0.51
ALDH1A1 P00352 3/20 0.50
GAA P10253 1/20 0.50
GFER P55789 1/20 0.50
TSHR P16473 3/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 1/20 0.47
HSP90AB1 P08238 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
CA2 P00918 3/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 1/20 0.41
SLC7A5 Q01650 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5522734 0.87 ALDH1A1 (0.50) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL13007382 0.86 ALDH1A1 (0.53) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL27471557 0.83 CYP4F2 (0.47) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL30632630 0.83 TSHR (0.62) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL298044 0.83 TSHR (0.62) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL2003361 0.80 ALDH1A1 (0.66) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL10229485 0.80 ALDH1A1 (0.53) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL20943277 0.79 ALDH1A1 (0.45) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL13696811 0.79 HSP90AB1 (0.49) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL377583 0.79 CYP4F2 (0.53) CYP4F2CYP4A11ALDH1A1GAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 US disclosed
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 US disclosed
US-20070203155-A1 Compounds And Compositions As Ppar Modulators IRM LLC (BM) 2007-08-30 US disclosed
EP-1748993-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2007-02-07 EP disclosed
WO-2005116000-A1 COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS IRM LLC (BM) 2005-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203155-A1 Compounds And Compositions As Ppar Modulators PPARG, PPARA, PPARD CYP4F2 1229/4885CYP4A11 394/4885ALDH1A1 1651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.